Monthly Communication Report

Organization:	Innovative Medicines Canada/Médicaments novateurs Canada
Associated registration:	778662-371-33
Communication date:	2013-07-10
Posted date:	2013-08-15

Designated Public Office Holders who participated in the communication:	Jonathan Aitchison, Senior Policy Advisor Industry Canada
Subject Matter of the communication:	Health,  Industry,  Intellectual Property,  International Trade
Communication Report amended on:	2013-08-14 previous entry: 371-286569
Reason for amendment:	As the result of the meeting occurring prior to the Government's reorganization, the title and department needed to be corrected to reflect the information prior to the reorganization, not the current GEDS' information.
Responsible Officer who filed this communication report:	RUSSELL WILLIAMS
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.